Status:

COMPLETED

Automated Screening of Diabetic Retinopathy Using a Smartphone-based Camera

Lead Sponsor:

Tameside General Hospital

Conditions:

Diabetic Retinopathy

Eligibility:

All Genders

18+ years

Brief Summary

The prevalence of diabetic retinopathy (DR) in the UK is on the rise. Within 20 years of diabetes diagnosis, nearly all people with type 1 and almost two thirds of people with type 2 diabetes (60%) ha...

Detailed Description

Study will enroll diabetic patients (new and established) meeting the inclusion criteria and who would provide an informed consent to participate in the study. This would include subjects who visit th...

Eligibility Criteria

Inclusion

  • Age above 18 years who can provide an informed consent
  • Established cases of diabetes mellitus (DM) with or without established diabetic retinopathy
  • Subjects who have been dilated for an ophthalmic evaluation previously

Exclusion

  • Patients with acute vision loss
  • Participants contraindicated for fundus imaging if hypersensitive to light or underwent recent photodynamic therapy or is photosensitive
  • Participants who have been treated for diabetic retinopathy (laser or intra-vitreal injections) in the past 3 months
  • Participants known to have other known retinal pathologies
  • Participants identified to be at risk of acute angle closure glaucoma from previous ophthalmic evaluation (anterior chamber depth, gonioscopy to look at angles and IOP)
  • Participants with known allergy to 1% tropicamide solution
  • Currently participating in another investigational eye study and/or actively receiving investigational product for DR or diabetic macula edema.
  • Participant has a condition that, in the opinion of the investigator, would preclude participation in the study (e.g., unstable medical status- glycemic control, blood pressure etc)

Key Trial Info

Start Date :

April 20 2022

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

August 24 2022

Estimated Enrollment :

410 Patients enrolled

Trial Details

Trial ID

NCT04732208

Start Date

April 20 2022

End Date

August 24 2022

Last Update

September 2 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Dr Edward Jude

Manchester, United Kingdom, OL6 9RW